BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 36012521)

  • 1. Targeting the Sphingolipid Rheostat in Gliomas.
    Zaibaq F; Dowdy T; Larion M
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The control of the balance between ceramide and sphingosine-1-phosphate by sphingosine kinase: oxidative stress and the seesaw of cell survival and death.
    Van Brocklyn JR; Williams JB
    Comp Biochem Physiol B Biochem Mol Biol; 2012 Sep; 163(1):26-36. PubMed ID: 22613819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sphingolipids and cancer: ceramide and sphingosine-1-phosphate in the regulation of cell death and drug resistance.
    Ponnusamy S; Meyers-Needham M; Senkal CE; Saddoughi SA; Sentelle D; Selvam SP; Salas A; Ogretmen B
    Future Oncol; 2010 Oct; 6(10):1603-24. PubMed ID: 21062159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective role of sphingolipid rheostat in excitotoxic retinal ganglion cell death.
    Nakamura N; Honjo M; Yamagishi R; Kurano M; Yatomi Y; Watanabe S; Aihara M
    Exp Eye Res; 2021 Jul; 208():108623. PubMed ID: 34022173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sphingolipid signaling pathways as potential therapeutic targets in gliomas.
    Van Brocklyn JR
    Mini Rev Med Chem; 2007 Oct; 7(10):984-90. PubMed ID: 17979800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles for C16-ceramide and sphingosine 1-phosphate in regulating hepatocyte apoptosis in response to tumor necrosis factor-alpha.
    Osawa Y; Uchinami H; Bielawski J; Schwabe RF; Hannun YA; Brenner DA
    J Biol Chem; 2005 Jul; 280(30):27879-87. PubMed ID: 15946935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sphingosine kinase, sphingosine-1-phosphate, and apoptosis.
    Maceyka M; Payne SG; Milstien S; Spiegel S
    Biochim Biophys Acta; 2002 Dec; 1585(2-3):193-201. PubMed ID: 12531554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism and biological functions of two phosphorylated sphingolipids, sphingosine 1-phosphate and ceramide 1-phosphate.
    Kihara A; Mitsutake S; Mizutani Y; Igarashi Y
    Prog Lipid Res; 2007 Mar; 46(2):126-44. PubMed ID: 17449104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sphingolipid metabolism in cancer signalling and therapy.
    Ogretmen B
    Nat Rev Cancer; 2018 Jan; 18(1):33-50. PubMed ID: 29147025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Remyelination Promoting Antibody Stimulates Astrocytes Proliferation Through Modulation of the Sphingolipid Rheostat in Primary Rat Mixed Glial Cultures.
    Grassi S; Giussani P; Prioni S; Button D; Cao J; Hakimi I; Sarmiere P; Srinivas M; Cabitta L; Sonnino S; Prinetti A
    Neurochem Res; 2019 Jun; 44(6):1460-1474. PubMed ID: 30569280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Rheostat of Ceramide and Sphingosine-1-Phosphate as a Determinant of Oxidative Stress-Mediated Kidney Injury.
    Ueda N
    Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Sphingolipid Mediators on the Determination of Cochlear Survival in Ototoxicity.
    Tabuchi K; Hara A
    Curr Mol Pharmacol; 2018; 11(4):279-284. PubMed ID: 29766830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Ceramide and Sphingosine-1-Phosphate in Alzheimer's Disease and Other Neurodegenerative Disorders.
    Czubowicz K; Jęśko H; Wencel P; Lukiw WJ; Strosznajder RP
    Mol Neurobiol; 2019 Aug; 56(8):5436-5455. PubMed ID: 30612333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Druggable Sphingolipid Pathways: Experimental Models and Clinical Opportunities.
    Blaho VA
    Adv Exp Med Biol; 2020; 1274():101-135. PubMed ID: 32894509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sphingolipids in neurodegeneration (with focus on ceramide and S1P).
    Wang G; Bieberich E
    Adv Biol Regul; 2018 Dec; 70():51-64. PubMed ID: 30287225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of autophagy and its associated cell death by "sphingolipid rheostat": reciprocal role of ceramide and sphingosine 1-phosphate in the mammalian target of rapamycin pathway.
    Taniguchi M; Kitatani K; Kondo T; Hashimoto-Nishimura M; Asano S; Hayashi A; Mitsutake S; Igarashi Y; Umehara H; Takeya H; Kigawa J; Okazaki T
    J Biol Chem; 2012 Nov; 287(47):39898-910. PubMed ID: 23035115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sphingolipids in macroautophagy.
    Lavieu G; Scarlatti F; Sala G; Carpentier S; Levade T; Ghidoni R; Botti J; Codogno P
    Methods Mol Biol; 2008; 445():159-73. PubMed ID: 18425450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer treatment strategies targeting sphingolipid metabolism.
    Oskouian B; Saba JD
    Adv Exp Med Biol; 2010; 688():185-205. PubMed ID: 20919655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altering the sphingosine-1-phosphate/ceramide balance: a promising approach for tumor therapy.
    Huwiler A; Pfeilschifter J
    Curr Pharm Des; 2006; 12(35):4625-35. PubMed ID: 17168766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antithetic role of ceramide and sphingosine-1-phosphate in cardiac dysfunction.
    Cirillo F; Piccoli M; Ghiroldi A; Monasky MM; Rota P; La Rocca P; Tarantino A; D'Imperio S; Signorelli P; Pappone C; Anastasia L
    J Cell Physiol; 2021 Jul; 236(7):4857-4873. PubMed ID: 33432663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.